Oracle (ORCL) Gets Price Target Cut From UBS After Mixed Earnings

UBS cut its Oracle price target to $325 from $380 while maintaining a Buy after December-quarter results slightly missed expectations — revenue grew 13% year-over-year and cloud infrastructure revenue rose 66% — and the firm cited mixed messaging on leverage/financing. UBS remains constructive on the company’s outlook because of a massive $523 billion backlog (which increased by $68 billion this quarter on Meta and Nvidia deals) and expects meaningful conversion into revenue in 2H/FY27, but noted that SaaS growth (11%) and the 3Q/Feb cloud revenue guide (37–41%) were below its forecasts and that investors will likely withhold further upside until backlog and capex more clearly translate into reported revenue.

Analysis

UBS lowered its Oracle price target to $325 from $380 while maintaining a Buy after December-quarter results on December 11 that slightly missed investor estimates. Reported revenue grew 13% year‑over‑year and cloud infrastructure revenue rose 66%, but UBS flagged mixed messaging on leverage and financing that tempered the print.

UBS pointed to a $523 billion remaining performance obligation backlog that increased by $68 billion this quarter driven by deals with Meta and Nvidia, and it expects meaningful conversion into revenue in 2H/FY27. The market reaction has cooled — the stock is no longer responding to incremental backlog growth — because investors want demonstrable translation of backlog and elevated capex into reported top‑line increases.

Operational details were mixed: SaaS growth was 11% (below Oracle’s guide), cloud infra was 66% (slightly below UBS’s 68% model), and the 3Q/Feb cloud revenue guide of 37–41% trailed UBS’s 42% estimate. These misses, together with a modest market‑impact score, indicate limited near‑term upside unless backlog conversion and cash‑flow/leverage clarity improve; successful conversion would substantively de‑risk the bullish case.

Key Decisions for Investors

• Maintain a cautious hold or limited Buy exposure and avoid increasing position size until Oracle demonstrates tangible backlog‑to‑revenue conversion and clearer capex translation in upcoming quarters
• Monitor specific near‑term indicators: quarterly revenue conversion from the $523B backlog, capex trends, cash‑flow and leverage commentary, and revenue recognition tied to the Meta and Nvidia deals
• Consider hedged or shorter‑duration exposure given the guidance and execution misses (SaaS 11%, cloud guide 37–41% vs UBS 42%); increase allocation only if conversion accelerates and analyst estimates are materially revised higher